526 related articles for article (PubMed ID: 28245785)
1. Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism.
Chrissobolis S
Curr Hypertens Rev; 2017; 13(1):46-56. PubMed ID: 28245785
[TBL] [Abstract][Full Text] [Related]
2. Mineralocorticoid antagonism and cardiac hypertrophy.
Nagata K
Curr Hypertens Rep; 2008 Jun; 10(3):216-21. PubMed ID: 18765093
[TBL] [Abstract][Full Text] [Related]
3. Does Aldosterone Play a Significant Role for Regulation of Vascular Tone?
Lyngsø KS; Assersen K; Dalgaard EG; Skott O; Jensen BL; Hansen PB
J Cardiovasc Pharmacol; 2016 Jul; 68(1):1-10. PubMed ID: 26657712
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor.
Dinh QN; Young MJ; Evans MA; Drummond GR; Sobey CG; Chrissobolis S
Brain Res; 2016 Apr; 1637():146-153. PubMed ID: 26923165
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone, mineralocorticoid receptor and the metabolic syndrome: role of the mineralocorticoid receptor antagonists.
Ronconi V; Turchi F; Appolloni G; di Tizio V; Boscaro M; Giacchetti G
Curr Vasc Pharmacol; 2012 Mar; 10(2):238-46. PubMed ID: 22022770
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension.
Whaley-Connell A; Johnson MS; Sowers JR
Prog Cardiovasc Dis; 2010; 52(5):401-9. PubMed ID: 20226958
[TBL] [Abstract][Full Text] [Related]
7. Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology.
Wilkinson-Berka JL; Tan G; Jaworski K; Harbig J; Miller AG
Circ Res; 2009 Jan; 104(1):124-33. PubMed ID: 19038868
[TBL] [Abstract][Full Text] [Related]
8. Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation.
Barrett KV; McCurley AT; Jaffe IZ
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):902-9. PubMed ID: 23710823
[TBL] [Abstract][Full Text] [Related]
9. Vascular actions of aldosterone.
Briet M; Schiffrin EL
J Vasc Res; 2013; 50(2):89-99. PubMed ID: 23172373
[TBL] [Abstract][Full Text] [Related]
10. New roles of aldosterone and mineralocorticoid receptors in cardiovascular disease: translational and sex-specific effects.
Davel AP; Jaffe IZ; Tostes RC; Jaisser F; Belin de Chantemèle EJ
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H989-H999. PubMed ID: 29957022
[TBL] [Abstract][Full Text] [Related]
11. Aldosterone in vascular and metabolic dysfunction.
Luther JM
Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):16-21. PubMed ID: 26575396
[TBL] [Abstract][Full Text] [Related]
12. Aldosterone and end-organ damage.
Marney AM; Brown NJ
Clin Sci (Lond); 2007 Sep; 113(6):267-78. PubMed ID: 17683282
[TBL] [Abstract][Full Text] [Related]
13. Vascular and inflammatory mineralocorticoid receptors in kidney disease.
Barrera-Chimal J; Jaisser F
Acta Physiol (Oxf); 2020 Feb; 228(2):e13390. PubMed ID: 31529757
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid Receptor Activation in Vascular Insulin Resistance and Dysfunction.
Igbekele AE; Jia G; Hill MA; Sowers JR; Jia G
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012219
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone and end-organ damage.
Brown NJ
Curr Opin Nephrol Hypertens; 2005 May; 14(3):235-41. PubMed ID: 15821416
[TBL] [Abstract][Full Text] [Related]
16. Mineralocorticoid Receptor Blockade in End-Stage Renal Disease.
Lyubarova R; Gosmanova EO
Curr Hypertens Rep; 2017 May; 19(5):40. PubMed ID: 28451852
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone and the risk of hypertension.
Xanthakis V; Vasan RS
Curr Hypertens Rep; 2013 Apr; 15(2):102-7. PubMed ID: 23378101
[TBL] [Abstract][Full Text] [Related]
18. Placental growth factor mediates aldosterone-dependent vascular injury in mice.
Jaffe IZ; Newfell BG; Aronovitz M; Mohammad NN; McGraw AP; Perreault RE; Carmeliet P; Ehsan A; Mendelsohn ME
J Clin Invest; 2010 Nov; 120(11):3891-900. PubMed ID: 20921624
[TBL] [Abstract][Full Text] [Related]
19. The ubiquitous mineralocorticoid receptor: clinical implications.
Hawkins UA; Gomez-Sanchez EP; Gomez-Sanchez CM; Gomez-Sanchez CE
Curr Hypertens Rep; 2012 Dec; 14(6):573-80. PubMed ID: 22843494
[TBL] [Abstract][Full Text] [Related]
20. Endothelial Dysfunction in Primary Aldosteronism.
Chen ZW; Tsai CH; Pan CT; Chou CH; Liao CW; Hung CS; Wu VC; Lin YH;
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31640178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
